Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

BPH treatments are improving with personalized medicine and better surgical options.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Mitotane changes steroid breakdown, affecting cortisol availability.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

SOX9 is essential for the development of various organs and hair follicles.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Improved CRBN ligands make protein degraders more effective and drug-like.

Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.

Testosterone's effects on COVID-19 are unclear and need more research.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Combining different treatments may be needed to effectively manage chronic prostatitis.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.